Latest Advances

  • Condition: Nephrotic Syndrome and Hyperlipidemia
  • Journal: Annals of palliative medicine
  • Treatment Used: Proportein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor
  • Number of Patients: 1
  • Published —
This case report describes a patient with nephrotic syndrome and hyperlipidemia.
  • Condition: Cancer
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Immune Checkpoint Inhibitor Therapy
  • Number of Patients: 309
  • Published —
The study researched the safety of immune checkpoint inhibitor therapy.
  • Condition: Pembrolizumab-associated Nephrotic Syndrome
  • Journal: CEN case reports
  • Treatment Used: Prednisolone
  • Number of Patients: 1
  • Published —
The study researched the outcomes of prednisolone for treating pembrolizumab-associated nephrotic syndrome.
  • Condition: Biopsy-Proven Minimal-Change Nephrotic Syndrome (MCNS) Concomitant with Allergic Disorders
  • Journal: Scientific reports
  • Treatment Used: Corticosteroid Reduction by Addition of Cetirizine and Montelukast
  • Number of Patients: 51
  • Published —
This study analyzed relapse and temporal daily corticosteroid dose with and without co-administration of histamine H1 receptor antagonist, cetirizine, and cysteinyl-leukotriene receptor antagonist, montelukast, as well as between baseline and after follow-up in patients with biopsy-proven minimal-change nephrotic syndrome (MCNS) concomitant with allergic disorders.
  • Condition: De Novo Minimal Change Disease
  • Journal: Clinical journal of the American Society of Nephrology : CJASN
  • Treatment Used: Tacrolimus and Prednisolone Monotherapy
  • Number of Patients: 50
  • Published —
The study researched the outcomes of Tacrolimus and Prednisolone alone for De Novo minimal change disease.
  • Condition: Ovarian Tumor and Glomerulopathies
  • Journal: The Pan African medical journal
  • Treatment Used: Surgery combined with Corticosteroids
  • Number of Patients: 11
  • Published —
This case report describes a patient who developed nephrotic syndrome in the setting of ovarian tumor treated with surgery combined with corticosteroids.
  • Condition: Neuroendocrine Tumors (NETs) and Glomerulonephritis
  • Journal: BMJ case reports
  • Treatment Used: Lanreotide
  • Number of Patients: 1
  • Published —
This article reported on a patient with neuroendocrine tumors (NETs) and glomerulonephritis treated with lanreotide.
  • Condition: Childhood-Onset Nephrotic Syndrome (NS)
  • Journal: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
  • Treatment Used: Steroid Therapy
  • Number of Patients: 55
  • Published —
This study investigated the relationship between endothelin-1 (ET1) and the response to steroid therapy in children with primary nephrotic syndrome.
  • Condition: Idiopathic Nephrotic Syndrome (INS)
  • Journal: Atherosclerosis. Supplements
  • Treatment Used: Immunoadsorption (IAS)
  • Number of Patients: 0
  • Published —
This article discusses the use of immunoadsorption (IAS) in the management of minimal change disease (MCD) and membranous nephropathy (MN) in idiopathic nephrotic syndrome (INS).
  • Condition: Idiopathic Nephrotic Syndrome
  • Journal: American journal of nephrology
  • Treatment Used: Oral Pulse Dexamethasone
  • Number of Patients: 13
  • Published —
This study tested the safety and efficacy of using oral pulse dexamethasone to treat patients with idiopathic nephrotic syndrome.
  • Condition: Adult-Onset Minimal Change Disease (MCD)
  • Journal: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
  • Treatment Used: Tacrolimus
  • Number of Patients: 1
  • Published —
This study tested the safety and efficacy of using tacrolimus to treat patients with adult-onset MCD.
  • Condition: Adult Steroid-Sensitive Minimal Change Disease (MCD)
  • Journal: American journal of nephrology
  • Treatment Used: Short-Term Steroid Regimen
  • Number of Patients: 35
  • Published —
This study tested the safety and efficacy of using a short-term steroid regimen to treat patients with adult steroid-sensitive MCD.
Showing 1-12 of 20